Race Oncology Ltd. | Income Statement
Fiscal year is July-June. All values AUD Thousands.
2014
2015
2016
2017
2018
Cost of Goods Sold (COGS) incl. D&A
-
-
-
250.00
250.90
Gross Income
-
-
-
250.00
250.90
SG&A Expense
15.20
85.70
496.20
3,792.20
6,078.20
EBIT
15.20
85.70
496.20
4,042.20
6,329.10
Unusual Expense
-
-
162.60
-
-
Non Operating Income/Expense
80.00
2.00
-
154.60
169.30
Interest Expense
-
-
1.20
-
-
Pretax Income
92.40
87.30
317.90
4,171.60
6,476.70
Income Tax
-
-
-
-
170.30
Consolidated Net Income
92.40
87.30
317.90
4,171.60
6,306.40
Net Income
92.40
87.30
317.90
4,171.60
6,306.40
Net Income After Extraordinaries
92.40
87.30
317.90
4,171.60
6,306.40
Net Income Available to Common
92.40
87.30
317.90
4,171.60
6,306.40
EPS (Basic)
0.00
0.00
0.01
0.08
0.09
Basic Shares Outstanding
52,687.50
52,687.50
52,687.50
52,734.40
67,401.70
EPS (Diluted)
0.00
0.00
0.01
0.08
0.09
Diluted Shares Outstanding
52,687.50
52,687.50
52,687.50
52,734.40
67,401.70
EBITDA
15.20
85.70
496.20
3,792.20
6,078.20
Non-Operating Interest Income
2.80
0.50
17.00
25.20
21.70
About Race Oncology
View Profile
